CTCF and breast carcinoma: Following Torin1 treatment at 25 nM, both CTCF+/− and CTCF-low MCF10A PDX lines were markedly sensitive to these low concentrations, being significantly more repressed in their ability to invade than the trio of breast cancer cell lines carrying higher CTCF levels (Fig. 3C).